|
Oncology
|
Infectious Diseases
|
CNS/Pain
|
Respiratory Respiratory
|
Respiratory
Maximising Opportunities Overcoming Challenges Respiratory drug development and commercialisation encompass improvements in existing classes of inhaled treatments as well as novel agents for more severe disease and rare respiratory conditions. Finding effective and safe new classes of drugs to treat asthma and COPD remains difficult. At TranScrip we are helping our biotech and pharma clients seize opportunities, address challenges and succeed in realising their drug development or lifecycle management goals by continually adapting and adopting new effective ways to work.
Internal Medicine
|